Potassium channel KCNA1 modulates oncogene-induced senescence and transformation.

Oncogene-induced senescence (OIS) constitutes a failsafe program that restricts tumor development. However, the mechanisms that link oncogenesis to senescence are not completely understood. We carried out a loss-of-function genetic screen that identified the potassium channel KCNA1 as a determinant of OIS escape that can license tumor growth. Oncogenic stress triggers an increase in KCNA1 expression and its relocation from the cytoplasm to the membrane. Mechanistically, this relocation is due to a loss of protein kinase A (PKA)-induced phosphorylation at residue S446 of KCNA1. Accordingly, sustaining PKA activity or expressing a KCNA1 phosphomimetic mutant maintained KCNA1 in the cytoplasm and caused escape from OIS. KCNA1 relocation to the membrane induced a change in membrane potential that invariably resulted in cellular senescence. Restoring KCNA1 expression in transformation-competent cells triggered variation in membrane potential and blocked RAS-induced transformation, and PKA activation suppressed both effects. Furthermore, KCNA1 expression was reduced in human cancers, and this decrease correlated with an increase in breast cancer aggressiveness. Taken together, our results identify a novel pathway that restricts oncogenesis through a potassium channel-dependent senescence pathway.

[1]  M. Nikiforov,et al.  Controversial aspects of oncogene-induced senescence , 2012, Cell cycle.

[2]  M. Jackson,et al.  TGF-β signaling engages an ATM-CHK2-p53–independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells , 2011, Proceedings of the National Academy of Sciences.

[3]  S. Baylin,et al.  Cancer epigenetics: linking basic biology to clinical medicine , 2011, Cell Research.

[4]  David F Jarrard,et al.  Therapy-induced senescence in cancer. , 2010, Journal of the National Cancer Institute.

[5]  S. Haferkamp,et al.  IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence , 2010, Cell.

[6]  P. Pandolfi,et al.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence , 2010, Nature.

[7]  Y. Pilpel,et al.  p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC , 2010, Cell Death and Differentiation.

[8]  N. Navaratnam,et al.  Regulation of ploidy and senescence by the AMPK‐related kinase NUAK1 , 2010, The EMBO journal.

[9]  P. Adams.  Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. , 2009, Molecular cell.

[10]  J. Chaudhuri,et al.  Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination , 2009, Nature Immunology.

[11]  Simon Tavaré,et al.  Autophagy mediates the mitotic senescence transition. , 2009, Genes & development.

[12]  D. Bernard,et al.  The M‐type receptor PLA2R regulates senescence through the p53 pathway , 2009, EMBO reports.

[13]  M. Marra,et al.  Protein kinase A as a biological target in cancer therapy , 2009, Expert opinion on therapeutic targets.

[14]  S. Raguz,et al.  Control of senescence by CXCR2 and its ligands , 2008, Cell cycle.

[15]  M. Brevet,et al.  Expression of K+ channels in normal and cancerous human breast. , 2008, Histology and histopathology.

[16]  F. D. D. Fagagna.  Living on a break: cellular senescence as a DNA-damage response , 2008, Nature Reviews Cancer.

[17]  D. Peeper,et al.  Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.

[18]  S. Raguz,et al.  Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.

[19]  L. Papa,et al.  The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells , 2007, Molecular and Cellular Biochemistry.

[20]  Eric S. Lander,et al.  Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene , 2007, Cell.

[21]  M. Fraga,et al.  The Polycomb group protein EZH2 directly controls DNA methylation , 2007, Nature.

[22]  C. Johannessen,et al.  A negative feedback signaling network underlies oncogene-induced senescence. , 2006, Cancer cell.

[23]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[24]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[25]  R. Weinberg,et al.  The signals and pathways activating cellular senescence. , 2005, The international journal of biochemistry & cell biology.

[26]  S. Glaser,et al.  cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. , 2004, Journal of hepatology.

[27]  D. Reinberg,et al.  Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. , 2004, Genes & development.

[28]  D. Bernard,et al.  Antiproliferative and antiapoptotic effects of crel may occur within the same cells via the up-regulation of manganese superoxide dismutase. , 2001, Cancer research.

[29]  T. Kitamura,et al.  Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.

[30]  T. Kiyono,et al.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.

[31]  B. Tempel,et al.  Cyclic AMP regulates potassium channel expression in C6 glioma by destabilizing Kv1.1 mRNA. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[33]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[34]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[35]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[36]  D. Chikvashvili,et al.  Phosphorylation of a K+ Channel α Subunit Modulates the Inactivation Conferred by a β Subunit , 1996, The Journal of Biological Chemistry.

[37]  G A Gutman,et al.  A family of three mouse potassium channel genes with intronless coding regions. , 1990, Science.

[38]  R. Weinberg,et al.  Characterization of a human colon/lung carcinoma oncogene , 1983, Nature.

[39]  M. Serrano,et al.  Senescence in tumours: evidence from mice and humans , 2010, Nature Reviews Cancer.

[40]  Esteban Ballestar,et al.  Epigenetic gene regulation in cancer. , 2008, Advances in genetics.

[41]  Goberdhan P Dimri,et al.  Mechanisms of cellular senescence in human and mouse cells , 2004, Biogerontology.

[42]  D. Chikvashvili,et al.  Phosphorylation of a K+ channel alpha subunit modulates the inactivation conferred by a beta subunit. Involvement of cytoskeleton. , 1996, The Journal of biological chemistry.